A detailed history of Prime Capital Investment Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 18,859 shares of NVS stock, worth $1.94 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
18,859
Previous 20,039 5.89%
Holding current value
$1.94 Million
Previous $2.13 Million 1.69%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$106.13 - $120.89 $125,233 - $142,650
-1,180 Reduced 5.89%
18,859 $2.17 Million
Q2 2024

Aug 08, 2024

SELL
$92.57 - $107.37 $126,728 - $146,989
-1,369 Reduced 6.39%
20,039 $2.13 Million
Q1 2024

May 14, 2024

BUY
$95.27 - $108.47 $110,227 - $125,499
1,157 Added 5.71%
21,408 $2.07 Million
Q4 2023

Jan 24, 2024

BUY
$92.27 - $101.54 $1.47 Million - $1.62 Million
15,927 Added 368.34%
20,251 $2.04 Million
Q3 2023

Nov 09, 2023

BUY
$94.73 - $105.13 $27,282 - $30,277
288 Added 7.14%
4,324 $440,000
Q2 2023

Aug 08, 2023

BUY
$92.52 - $104.91 $128,325 - $145,510
1,387 Added 52.36%
4,036 $407,000
Q1 2023

May 05, 2023

SELL
$80.03 - $92.81 $38,494 - $44,641
-481 Reduced 15.37%
2,649 $243,000
Q4 2022

Feb 08, 2023

BUY
$75.55 - $92.52 $236,471 - $289,587
3,130 New
3,130 $283,000
Q4 2019

Feb 04, 2020

SELL
$84.35 - $95.37 $19,400 - $21,935
-230 Closed
0 $0
Q3 2019

Nov 05, 2019

SELL
$85.54 - $94.26 $26,175 - $28,843
-306 Reduced 57.09%
230 $20,000
Q2 2019

Aug 06, 2019

BUY
$75.4 - $92.8 $40,414 - $49,740
536 New
536 $49,000
Q1 2018

May 01, 2018

SELL
$70.39 - $84.15 $2,393 - $2,861
-34 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$72.33 - $77.64 $2,459 - $2,639
34
34 $3,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Prime Capital Investment Advisors, LLC Portfolio

Follow Prime Capital Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prime Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prime Capital Investment Advisors, LLC with notifications on news.